Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4540293
Max Phase: Preclinical
Molecular Formula: C20H22F3N3O3S
Molecular Weight: 441.48
Molecule Type: Unknown
Associated Items:
ID: ALA4540293
Max Phase: Preclinical
Molecular Formula: C20H22F3N3O3S
Molecular Weight: 441.48
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ccccc1N1CCN(C(=O)C(C)S(=O)(=O)c2ccc(C(F)(F)F)cn2)CC1
Standard InChI: InChI=1S/C20H22F3N3O3S/c1-14-5-3-4-6-17(14)25-9-11-26(12-10-25)19(27)15(2)30(28,29)18-8-7-16(13-24-18)20(21,22)23/h3-8,13,15H,9-12H2,1-2H3
Standard InChI Key: MVIBQYZAWQHOPF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 441.48 | Molecular Weight (Monoisotopic): 441.1334 | AlogP: 2.92 | #Rotatable Bonds: 4 |
Polar Surface Area: 70.58 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.31 | CX Basic pKa: 3.62 | CX LogP: 3.46 | CX LogD: 3.46 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.73 | Np Likeness Score: -1.83 |
1. Seleem MA, Rodrigues de Almeida N, Chhonker YS, Murry DJ, Guterres ZDR, Blocker AM, Kuwabara S, Fisher DJ, Leal ES, Martinefski MR, Bollini M, Monge ME, Ouellette SP, Conda-Sheridan M.. (2020) Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases., 63 (8): [PMID:32227948] [10.1021/acs.jmedchem.0c00371] |
Source(1):